Inhaltsbereich
| 113 Einträge | 1, 2, 3, 4, 5, 6 › » |
Seite 1 / 6
 Druckansicht
|
| Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial. |
| Kwon ED, Drake CG, Scher HI, Fizazi K, Bossi A, van den Eertwegh AJ, Krainer M, Houede N, Santos R, Mahammedi H, Ng S, Maio M, Franke FA, Sundar S, Agarwal N, Bergman AM, Ciuleanu TE, Korbenfeld E, Sengeløv L, Hansen S, Logothetis C, Beer TM, McHenry MB, Gagnier P, Liu D, Gerritsen WR |
| The Lancet. Oncology. 2014 May 13. pii: S1470-2045(14)70189-5. doi: 10.1016/S1470-2045(14)70189-5. pmc: PMC4418935. mid: NIHMS677780 |
| PMID: 24831977 |
| Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1. |
| Smith M, De Bono J, Sternberg C, Le Moulec S, Oudard S, De Giorgi U, Krainer M, Bergman A, Hoelzer W, De Wit R, Bögemann M, Saad F, Cruciani G, Vuillemin AT, Feyerabend S, Miller K, Houédé N, Hussain S, Lam E, Polikoff J, Stenzl A, Mainwaring P, Ramies D, Hessel C, Weitzman A, Fizazi K |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Jul 11. pii: JCO.2015.65.5597. doi: 10.1200/JCO.2015.65.5597 |
| PMID: 27400947 |
| The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer. |
| Heinrich D, Bektic J, Bergman AM, Caffo O, Cathomas R, Chi KN, Daugaard G, Keizman D, Kindblom J, Kramer G, Olmos D, Omlin A, Sridhar SS, Tucci M, van Oort I, Nilsson S |
| Clinical genitourinary cancer. 2017 Sep 6. pii: S1558-7673(17)30275-6. doi: 10.1016/j.clgc.2017.08.020 |
| PMID: 29079165 |
| Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. |
| Fizazi K, Drake CG, Beer TM, Kwon ED, Scher HI, Gerritsen WR, Bossi A, den Eertwegh AJMV, Krainer M, Houede N, Santos R, Mahammedi H, Ng S, Danielli R, Franke FA, Sundar S, Agarwal N, Bergman AM, Ciuleanu TE, Korbenfeld E, Sengeløv L, Hansen S, McHenry MB, Chen A, Logothetis C |
| European urology. 2020 Aug 15. pii: S0302-2838(20)30604-7. doi: 10.1016/j.eururo.2020.07.032 |
| PMID: 32811715 |
| Everolimus for patients with metastatic renal cell carcinoma refractory to anti-VEGF therapy: Results of a pooled analysis of non-interventional studies. |
| Albiges L, Kube U, Eymard JC, Schmidinger M, Bamias A, Kelkouli N, Mraz B, Florini S, Guderian G, Cattaneo A, Bergmann L |
| European journal of cancer (Oxford, England : 1990). 2015 Aug 11. pii: S0959-8049(15)00710-8. doi: 10.1016/j.ejca.2015.07.030 |
| PMID: 26276039 |
| Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia. |
| Johansson P, Bergmann A, Rahmann S, Wohlers I, Scholtysik R, Przekopowitz M, Seifert M, Tschurtschenthaler G, Webersinke G, Jäger U, Siebert R, Klein-Hitpass L, Dührsen U, Dürig J, Küppers R |
| International journal of cancer. Journal international du cancer. 2015 Jul 21. doi: 10.1002/ijc.29697 |
| PMID: 26199174 |
| Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis. |
| von Karstedt S, Conti A, Nobis M, Montinaro A, Hartwig T, Lemke J, Legler K, Annewanter F, Campbell AD, Taraborrelli L, Grosse-Wilde A, Coy JF, El-Bahrawy MA, Bergmann F, Koschny R, Werner J, Ganten TM, Schweiger T, Hoetzenecker K, Kenessey I, Hegedüs B, Bergmann M, Hauser C, Egberts JH, Becker T, Röcken C, Kalthoff H, Trauzold A, Anderson KI, Sansom OJ, Walczak H |
| Cancer cell. 2015 Apr 2. pii: S1535-6108(15)00064-1. doi: 10.1016/j.ccell.2015.02.014 |
| PMID: 25843002 |
| LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines. |
| Aschacher T, Wolf B, Enzmann F, Kienzl P, Messner B, Sampl S, Svoboda M, Mechtcheriakova D, Holzmann K, Bergmann M |
| Oncogene. 2015 Mar 23. pii: onc201565. doi: 10.1038/onc.2015.65 |
| PMID: 25798839 |
| Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases. |
| Schweiger T, Nikolowsky C, Starlinger P, Traxler D, Zimmermann M, Birner P, Hegedüs B, Dome B, Bergmann M, Mildner M, Klepetko W, Hoetzenecker K, Ankersmit HJ |
| PloS one. 2015 Mar 20. doi: 10.1371/journal.pone.0120724. pii: PONE-D-14-36879. pmc: PMC4368667 |
| PMID: 25793600 |
| A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV. |
| Bergmann L, Maute L, Heil G, Rüssel J, Weidmann E, Köberle D, Fuxius S, Weigang-Köhler K, Aulitzky WE, Wörmann B, Hartung G, Moritz B, Edler L, Burkholder I, Scheulen ME, Richly H |
| European journal of cancer (Oxford, England : 1990). 2014 Nov 5. pii: S0959-8049(14)01009-0. doi: 10.1016/j.ejca.2014.10.010 |
| PMID: 25459392 |
| B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer. |
| Meshcheryakova A, Tamandl D, Bajna E, Stift J, Mittlboeck M, Svoboda M, Heiden D, Stremitzer S, Jensen-Jarolim E, Grünberger T, Bergmann M, Mechtcheriakova D |
| PloS one. 2014 Jun 6. doi: 10.1371/journal.pone.0099008. pii: PONE-D-14-04301. pmc: PMC4048213 |
| PMID: 24905750 |
| Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia. |
| Pflug N, Bahlo J, Shanafelt TD, Eichhorst BF, Bergmann MA, Elter T, Bauer K, Malchau G, Rabe KG, Stilgenbauer S, Döhner H, Jäger U, Eckart MJ, Hopfinger G, Busch R, Fink AM, Wendtner CM, Fischer K, Kay NE, Hallek M |
| Blood. 2014 May 5. pii: blood-2014-02-556399. doi: 10.1182/blood-2014-02-556399. pmc: PMC4260976 |
| PMID: 24797299 |
| Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. |
| Stilgenbauer S, Schnaiter A, Paschka P, Zenz T, Rossi M, Döhner K, Bühler A, Böttcher S, Ritgen M, Kneba M, Winkler D, Tausch E, Hoth P, Edelmann J, Mertens D, Bullinger L, Bergmann M, Kless S, Mack S, Jäger U, Patten N, Wu L, Wenger MK, Fingerle-Rowson G, Lichter P, Cazzola M, Wendtner CM, Fink AM, Fischer K, Busch R, Hallek M, Döhner H |
| Blood. 2014 Mar 20. pii: blood-2014-01-546150. doi: 10.1182/blood-2014-01-546150 |
| PMID: 24652989 |
| Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients. |
| Petricevic B, Laengle J, Singer J, Sachet M, Fazekas J, Steger G, Bartsch R, Jensen-Jarolim E, Bergmann M |
| Journal of translational medicine. 2013 Dec 12. pii: 1479-5876-11-307. doi: 10.1186/1479-5876-11-307. pmc: PMC4029549 |
| PMID: 24330813 |
| IL-24 sensitizes tumor cells to TLR3-mediated apoptosis. |
| Weiss R, Sachet M, Zinngrebe J, Aschacher T, Krainer M, Hegedus B, Walczak H, Bergmann M |
| Cell death and differentiation. 2013 Mar 1. pii: cdd201315. doi: 10.1038/cdd.2013.15. pmc: PMC3647237 |
| PMID: 23449395 |
| Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer. |
| Arnold T, Michlmayr A, Baumann S, Burghuber C, Pluschnig U, Bartsch R, Steger G, Gnant M, Bergmann M, Bachleitner-Hofmann T, Oehler R |
| European journal of clinical investigation. 2013 Jan 25. doi: 10.1111/eci.12043 |
| PMID: 23410002 |
| Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer. |
| Schauer D, Starlinger P, Reiter C, Jahn N, Zajc P, Buchberger E, Bachleitner-Hofmann T, Bergmann M, Stift A, Gruenberger T, Brostjan C |
| PloS one. 2012 Sep 4. doi: 10.1371/journal.pone.0044450. pii: PONE-D-12-05747. pmc: PMC3433422 |
| PMID: 22973451 |
| Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma. |
| Rohr-Udilova N, Sieghart W, Eferl R, Stoiber D, Björkhem-Bergman L, Eriksson LC, Stolze K, Hayden H, Keppler B, Sagmeister S, Grasl-Kraupp B, Schulte-Hermann R, Peck-Radosavljevic M |
| Hepatology (Baltimore, Md.). 2012 Mar 30. doi: 10.1002/hep.24808 |
| PMID: 22105228 |
| Monitoring tumor motion by real time 2D/3D registration during radiotherapy. |
| Gendrin C, Furtado H, Weber C, Bloch C, Figl M, Pawiro SA, Bergmann H, Stock M, Fichtinger G, Georg D, Birkfellner W |
| Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2011 Aug 30. pii: S0167-8140(11)00409-9. doi: 10.1016/j.radonc.2011.07.031. pmc: PMC3276833. mid: UKMS41030 |
| PMID: 21885144 |
| High-performance GPU-based rendering for real-time, rigid 2D/3D-image registration and motion prediction in radiation oncology. |
| Spoerk J, Gendrin C, Weber C, Figl M, Pawiro SA, Furtado H, Fabri D, Bloch C, Bergmann H, Gröller E, Birkfellner W |
| Zeitschrift für medizinische Physik. 2011 Jul 22. pii: S0939-3889(11)00065-1. doi: 10.1016/j.zemedi.2011.06.002. pmc: PMC3378472. mid: UKMS47267 |
| PMID: 21782399 |
| 113 Einträge | 1, 2, 3, 4, 5, 6 › » |
Seite 1 / 6
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
